#transfection | Explore Tumblr Posts and Blogs

poojascmi · 10 months

Text

Global Transfection Reagents and Equipment Market Is Estimated To Witness High Growth Owing To Growing Demand for Gene Therapy

The Global Transfection Reagents and Equipment Market is estimated to be valued at US$1,066.5 million in 2022 and is expected to exhibit a CAGR of 9.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: Transfection reagents and equipment are used in the process of introducing nucleic acids into cells. They play a crucial role in molecular biology research, gene therapy, and biopharmaceutical production. These products offer several advantages such as efficient DNA transfer, high transfection rates, low cytotoxicity, and compatibility with various cell types. The need for these products arises from the increasing demand for gene therapy and the growing focus on precision medicine. Transfection reagents and equipment enable researchers to study gene functions, protein expression, and cellular processes, leading to advancements in the understanding and treatment of various diseases. B) Market Key Trends: One key trend observed in the Transfection Reagents and Equipment market is the growing demand for gene therapy. Gene therapy has emerged as a promising approach for the treatment of genetic disorders, cancer, and other diseases. It involves the delivery of therapeutic genes into target cells to correct genetic abnormalities or enhance cellular functions. Transfection reagents and equipment play a crucial role in the efficient delivery of therapeutic genes, making them an essential component of gene therapy. The advancements in gene editing technologies like CRISPR-Cas9 have further fueled the demand for transfection reagents and equipment, as they enable precise and efficient gene editing. For example, CRISPR-Cas9 technology has shown great promise in treating sickle cell disease, a genetic disorder characterized by abnormal hemoglobin production. Researchers used transfection reagents to deliver CRISPR-Cas9 components into the bone marrow cells of a patient and successfully corrected the genetic mutation underlying the disease. This breakthrough highlights the transformative potential of gene therapy and the importance of transfection reagents and equipment in enabling such advancements. C) PEST Analysis: Political: The political landscape can influence the Transfection Reagents and Equipment market. Government regulations and policies related to genetic research and gene therapy can impact the development and commercialization of transfection reagents and equipment. Economic: Economic factors, such as healthcare expenditure, funding for research and development, and availability of healthcare infrastructure, can impact the demand for transfection reagents and equipment. Social: Social factors, including increasing awareness about genetic disorders, advancements in healthcare technologies, and the need for personalized medicine, are driving the adoption of transfection reagents and equipment. Technological: Technological advancements in gene editing technologies, such as CRISPR-Cas9, are fueling the demand for transfection reagents and equipment. Continuous innovation in transfection reagents and equipment is also driving market growth. D) Key Takeaways: Paragraph 1: The Global Transfection Reagents And Equipment Market Size is expected to witness high growth, exhibiting a CAGR of 9.3% over the forecast period. This growth is attributed to increasing demand for gene therapy, driven by advancements in gene editing technologies like CRISPR-Cas9. For example, the successful correction of genetic mutations underlying diseases using transfection reagents and equipment highlights their importance in gene therapy. Paragraph 2: Regionally, North America is expected to dominate the Transfection Reagents and Equipment market due to its well-established healthcare infrastructure, significant investments in research and development, and strong presence of key market players. Europe is also expected to witness substantial growth owing to increasing government support for genetic research and rising adoption of gene therapy.

#Transfection Reagents and Equipment Market #Transfection Reagents and Equipment #Transfection Reagents and Equipment Market Forecast

0 notes

poojaj · 1 year

Text

Transfection Kits Market to Witness Huge Growth by 2030

The Transfection kits market refers to the global market for kits used in the process of transfection. Transfection is a widely used laboratory technique for introducing nucleic acids (DNA or RNA) into cells, enabling the study and manipulation of gene expression and cellular function.

For Sample Report Click Here:- https://www.marketinforeports.com/Market-Reports/Request-Sample/511542

Transfection kits typically contain reagents and protocols necessary for efficient delivery of nucleic acids into cells. These kits may include transfection reagents, such as lipids, polymers, or nanoparticles, as well as buffers, media, and other components required for the transfection process. The kits are designed to optimize transfection efficiency, minimize cell toxicity, and provide consistent and reliable results.

The transfection kits market has experienced significant growth in recent years due to the increasing demand for genetic research, drug discovery and development, and gene therapy. Transfection is widely used in various fields of research, including molecular biology, cell biology, cancer research, and neuroscience, among others.

Key factors driving the growth of the transfection kits market include advancements in transfection technologies, the rise in genetic engineering research, and the increasing adoption of gene therapy for the treatment of genetic disorders and diseases. Additionally, the growing focus on personalized medicine and the development of novel therapies based on gene editing techniques, such as CRISPR-Cas9, have further fueled the demand for transfection kits.

The market is highly competitive, with several major players and numerous smaller companies offering a wide range of transfection kits. These companies continuously invest in research and development activities to enhance the performance and efficiency of their products. They also engage in strategic collaborations and partnerships with academic institutions, biotechnology companies, and pharmaceutical companies to expand their product offerings and market presence.

Geographically, North America has traditionally held a significant share in the transfection kits market, primarily due to the presence of major biotechnology and pharmaceutical companies, as well as academic research institutions. However, the market is also witnessing rapid growth in Asia-Pacific, driven by increasing investments in life sciences research and the emergence of several biotechnology hubs in countries like China and India.

#Transfection Kits Market #Transfection Kits

0 notes

statisticalmarketreport · 1 year

Link

#usa transfection reagent market

0 notes

market-insider · 1 year

Text

Cell-Specific Transfection Reagents and Equipment: Market Dynamics and Opportunities

Transfection is a fundamental technique used in molecular biology to introduce foreign nucleic acids, such as DNA or RNA, into cells for various applications such as gene expression analysis, protein production, and genome editing. Transfection reagents and equipment are essential components of this process, providing the necessary tools to facilitate efficient and specific delivery of nucleic acids to cells. The reagents used in transfection include cationic lipids, polymers, and nanoparticles, which can effectively interact with the nucleic acids and mediate their delivery into cells. Equipment such as electroporators, microinjectors, and gene guns can also be used to introduce nucleic acids into cells with varying levels of efficiency and specificity. The choice of transfection reagent and equipment is dependent on the cell type, nucleic acid type, and desired outcome of the experiment. Thus, careful consideration should be given to these factors when selecting transfection reagents and equipment.

Transfection Reagents & Equipment Market Trends

The transfection reagents and equipment market has been rapidly expanding in recent years, driven by the increasing demand for gene therapy and genome editing applications. One of the latest developments in the market is the introduction of CRISPR/Cas9-based transfection reagents, which can specifically target and edit genes with high efficiency and accuracy. These reagents have shown great promise in treating genetic diseases and cancers. Another significant development is the emergence of nanoparticle-based transfection reagents, which can deliver nucleic acids to cells more efficiently than traditional methods. These reagents have a lower toxicity profile and can target specific cell types or tissues, allowing for more precise and effective delivery of therapeutics. In addition, the demand for automated transfection equipment has been increasing, as it can streamline and simplify the transfection process, reducing the potential for human error and increasing throughput. Several companies have introduced automated transfection systems that can perform high-throughput transfections in a variety of cell types.

Gain deeper insights on the market and receive your free copy with TOC now @: Transfection Reagents & Equipment Market Report

The global transfection reagents & equipment market size is expected to reach USD 1.4 billion by 2025, expanding at a CAGR of 7.7%, according to a new report by Grand View Research, Inc. The latest polymeric formulations-based compounds are gentle to cells as compared to cationic liposomes and these products render higher gene-delivery efficiency, further promoting the development of unique transfection products in the market.

Moreover, multi-component reagents such as X-tremeGENE provided by F. Hoffmann-La Roche AG, deliver high efficiency and minimal cytotoxicity than traditional ones comprising only one-component formulations. Thus, companies are keen on offering cutting-edge transfection solutions, in turn, offering significant momentum to market growth.

#Transfection Reagents And Equipment Market Size & Share #Global Transfection Reagents And Equipment Market #Transfection Reagents And Equipment Market Latest Trends #Transfection Reagents And Equipment Market Growth Forecast #COVID-19 Impacts On Transfection Reagents And Equipment Market #Transfection Reagents And Equipment Market Revenue Value

0 notes

patientmakt · 5 months

Text

#covid vaccine #mrna vaccine #patientsafety #mrnacovid #covid 19 #covid19 #coronavirus #covid vax #mrna #long covid #post covid #the jab #transfection #nanotechnology #medicalharm #health #medicine #research

0 notes

marketingnews1212 · 2 years

Text

Transfection Technologies Market - Forecast 2022-2027

#Transfection Technologies Market price #Transfection Technologies Market size #Transfection Technologies Market share #Transfection Technologies Market report #Transfection Technologies Market trends

0 notes

marketinsightshare · 2 years

Text

Transfection Technologies Market - Forecast, 2022-2027

Transfection Technologies Market size is estimated to reach $1.7 billion by 2027, growing at a CAGR of 8.1% during the forecast period 2022-2027. Transfection can be delineated as a method taken into consideration to introduce naturally occurring chemical compounds that are nucleic acids into cells. Nucleic acids such as deoxyribonucleic acid and ribonucleic acid are considered to alter the genetic content of host cells. It isn’t a piece of cake to penetrate a cell and introduce foreign nucleic acids as the cellular membrane shields them from the outer environment. Therefore, several microbiology techniques like electroporation and magnet assisted transfection is used to broaden the porousness of the cell membrane so that chemicals or DNA can be introduced without any hindrance. The transfection technologies market outlook is exceptionally bewitching as they have a wide range of applications in coming across detailed biomarkers by getting the hang of molecular pathway of maladies and these biomarkers can be useful in the diagnosis of ailments like cancer. Far-reaching applications in protein production and vaccine development, proliferation in the prevalence of cancer and other chronic illnesses as the geriatric population is on a precipitous upsurge are the most prominent factors set to drive the growth of the Transfection Technologies Market for the period 2022-2027.

Report Coverage

The report: “Transfection Technologies Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Transfection Technologies Market.

By Application: Research (cancer research, biomedical research), Therapeutics, Protein production and studies, and others. By Method Type: Biological methods (virus-mediated transfection or transduction), Chemical based transfection (magnetic beads, Cationic amino acids and polymers, lipofection, cationic lipids, calcium phosphate, and others), Instrument based method (Biolistic particle delivery, laserfection, electroporation, direct microinjection, and others). By Technology: Biochemical, Physical, and Viral-Vector based Transfection. By End User: Hospitals, Research laboratories, Pharma and Biopharmaceutical firms, Academic institutions. By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of World (the Middle East and Africa).

Key Takeaways

Geographically, the North America Transfection Technologies Market accounted for the highest revenue share in 2021. However, Asia-pacific is poised to dominate the market over the period 2022-2027.

Heightening research and development activities associated with novel discoveries of drugs and transfection techniques and enlarging demand for precise therapeutic procedures are said to be preeminent drivers driving the growth of the Transfection Technologies Market. Moreover, the grim requirement of innumerable hard cash and cell damage incidences due to transfection are said to reduce the market growth.

Detailed analysis of the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Transfection Technologies Market report.

Transfection Technologies Market Share, By Geography (%) in 2021

For More Details on This Report - Request for Sample

Transfection Technologies Market Segment Analysis-By Technology Type

The Transfection Technologies Market based on the technology type can be further segmented into biological methods (virus-mediated transfection or transduction), chemical-based transfection (magnetic beads, cationic amino acids and polymers, lipofection, cationic lipids, calcium phosphate, and others), Instrument based method (Biolistic particle delivery, laserfection, electroporation, direct microinjection, and others). The biological and chemical-based method segment held the largest share in 2021. The growth is owing to the high preciseness of the viral vector as compared to gene transduction as virus-mediated transfection makes use of a viral vector to deliver DNA and RNA into the cells. Biological methods are used frequently owing to their meticulousness in gene delivery. Moreover, viral vector in transduction extends the advantages of easy permeability in cells that are quite rigid to bisect making it easy to accomplish transgene countenance in vivo. On another hand, chemical-based methods are very cost-effective and easy to use making them the first choice of many researchers. However, the Instrument-based segment is estimated to be the fastest-growing segment with a CAGR of 9.8% over the forecast period 2022-2027. This growth is owing to their flexibility and ease of working with a diversity of cells. Moreover, these methods are quite well-organized therefore can be operated in alive organisms.

Transfection Technologies Market Segment Analysis-By End User

The Transfection Technologies Market based on end-user can be further segmented into Hospitals, Research laboratories, Pharma and Biopharmaceutical firms, and Academic institutions. The pharmaceutical and biopharmaceutical along segment held the largest share in 2021. The growth is owing to round-the-clock research activities in an attempt to develop an effective cure for COVID-19 vaccines. The demand for acetaminophen and ivermectin as corona cases are spiking ensuring billions of dollars to pharmaceutical companies. As a result, companies have heightened their quest for vaccine developments where transfection technologies play a crucial role. Moreover, this same segment is estimated to be the fastest-growing segment with a CAGR of 9.3% over the forecast period 2022-2027. This growth is owing to the ineffectiveness of vaccines against mutated variants of the COVID-19. The pharma and biopharma companies are slogging through too much as the prevalence of cancer is expected to reach epidemic proportions in foreseeable future.

Transfection Technologies Market Segment Analysis-By Geography

The Transfection Technologies Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share with 38% of the overall market in 2021. The growth in this segment is owing to the factors such as the presence of state-of-the-art research laboratories and top-flight pharmaceutical players that are assisting in research and development at a relentless pace. The full-fledged economies of North American states subject them to spending an incalculable amount of riches to develop contemporary cures. Moreover, plunging incidences of obesity and breast cancer among people in the US is another big factor in the dominance of this segment in the transfection technologies market. Nevertheless, the Asia-pacific segment is expected to be the fastest-growing segment over the forecast period 2022-2027. This growth is owing to heightened incidences of infections attributed to poor intake and bizarre eating habits, especially in nations like China, Thailand, and India. On another hand, due to the upsurging old-age population cardiovascular illnesses are griping this continent. Nevertheless, the rising wealth of countries is encouraging them to refine their existing healthcare infrastructure and research proficiencies.

Transfection Technologies Market Drivers

Expanding incidences of chronic illnesses are Anticipated to Boost Product Demand

The accruing chronic maladies and viral infections are the primary reason behind broadening mortality rates and the number of hospitalizations around the globe. With declining, immunities people are turning more prone to such illnesses. As of 2021, more than 14% of an adult residing in the U.S. were reported with more than 1 chronic ailment. In addition to that, 43-44% of millennials who are in their early 40s are afflicted with some sort of chronic condition. Besides, around 1.9 million cases of cancer were found worldwide which eventually led to more than 600,000 fatalities in 2021. Moreover, over 130,000 deaths are being reported every year in the US due to lung cancer. Considering these trends, the demand for transfection technologies has heightened in recent years.

Heightened flows of riches in research and development as communicable viruses are griping the world are Expected to Boost Product Demand

The private players in the market have increased their efforts to overcome the drawbacks of existing transfection technologies. For instance, Thermo Fisher scientific a major player in the transfection technologies market increase its research spending by more than $150 million in 2020 when it allocated around $1,181 million to research and development. The numbers are bound to rise with the rising profit of pharmaceutical companies due to the pandemic and are anticipated to drive the market forward.

Transfection Technologies Market Challenges

The exorbitant cost of instruments and drawback of transfection methods is Anticipated to Hamper Market Growth

The instruments required to perform the transfection process are expensive which can be a challenge for the market. Even though chemical transfection methods are slightly cost-effective but they are prone to errors also. Moreover, the usage of chemicals like calcium phosphate can affect cell functioning adversely. The total DNA amount used in calcium phosphate transfection is usually 10–50 ?g in 450 ?L sterile water and 50 ?L of 2.5 M CaCl2 per 10-cm dish but varies widely among plasmid preparations as well as with different cells and media. Methods like electroporation and microinjections are considered harmful as they can mutilate the cells during the penetration of the cellular membrane due to larger pores and ion imbalance which is anticipated to cripple the growth of the transfection technologies market.

Transfection Technologies Industry Outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Transfection Technologies Market. Key companies in this market are-

Lonza Group

Qiagen

Sigma Aldrich

Thermo Fisher

Bio-Rad Laboratories Inc.

Life technologies

Roche Holding AG

Promega Corporation

SignaGen Laboratories

Polyplus-Transfection

Recent Developments

On February 3, 2022, Polypus, a provider of transfection reagents acquired e-Zyvec, a France-based provider of DNA design and production services for custom-made DNA vectors to expand their expertise in the plasmid DNA vector engineering.

On April 15, 2021, US-based company “Thermo Fisher Scientific” which is famous for its reagent and other instrument supplies concluded the acquisition of US-based CRO “Pharmaceutical Product Development.” A payment of $17.4 billion was made to PPD. The acquisition strengthens the clinical research portfolio of Thermo Fisher.

On April 9, 2020, California, United States-based company “Bio-Rad Laboratories” which develops special technology for life science successfully acquired the company “Celsee.” Celsee is a US-based firm that deals in transfection technologies. The financials

#Transfection Technologies Market share #Transfection Technologies Market size #Transfection Technologies Market forecast

0 notes